Bilateral deep brain stimulation of the anterior limb of the internal capsule shows promise as treatment for patients with intractable major depression
Bilateral deep brain stimulation of the anterior
limb of the internal capsule shows promise as treatment for patients
with intractable major depression, according to a presentation at
the annual meeting of the American Association of Neurological Surgeons.
“Since 2001, this team of investigators has been using deep brain
stimulation (DBS) for treatment of obsessive compulsive disorder
(OCD). Because DBS for OCD showed significant benefits in improving
patient’s anxiety and obsessions, as well as improvements in co-morbid
depression, the research team initiated a new study analyzing the
effects of DBS on patients with major depression,” Rezai explained.
The technique has been used to treat intractable pain for several
decades, and has seen usage expanded recently to Parkinson’s disease
and other movement disorders. Research is studying its potential
in patients with intractable epilepsy.
The surgery involves implantation of tiny electrodes into specific
parts of the brain. The electrodes emit tiny pulses of electrical
stimulation to block abnormal neuronal activity. Success is dependent
on the surgical team’s ability to precisely pinpoint the specific
brain area for stimulation. An advantage of the technique is that
it is reversible, nondestructive, and can be modified by adjustment
of the stimulator settings after implantation.
In the current study, 6 patients, 4 women and 2 men (average age,
48) with a history of depression resistant to other treatments including
medication, psychotherapy, and electroconvulsive therapy (ECT) were
enrolled.
Bilateral leads were implanted stereotactically in the ventral
anterior internal capsule. Participants underwent standardized and
detailed psychiatric, quality-of-life, and neuropsychological assessments
on a regularly scheduled basis, both before and after their procedures.
At a minimum of 6 postoperative months, 4 of the 6 patients showed
a clinically significant reduction in depression severity of 50
percent or greater on the Montgomery-Asberg Depression Rating Scale.
Quality-of-life measures improved as well, and patients showed progressive
improvements in mood and functioning over time. One patient experienced
persistent occipital pain that was alleviated with repositioning
of a subcutaneous connector wire.
Rezai also commented on patients with obsessive compulsive disorder
(OCD) who had been previously treated by the same team: “In following
9 patients for a minimum of 2 years, we concluded that bilateral
deep brain stimulation of the anterior limb of the internal capsule
is a safe and effective therapy for patients with intractable OCD
that were previously unresponsive to all other available therapeutic
alternatives.”
|